HB 935 creates the Joint Legislative Committee on Medicaid Oversight within the Office of the Auditor General. The committee would be made up of three senators and three representatives, meet at least twice a year, and be able to form subcommittees. Its stated purpose is to review whether Florida’s Medicaid program is operating as intended, with a focus on transparency, efficiency, program financing, quality of care, health outcomes, and administrative and operational performance.
The bill gives the committee broad review authority over Medicaid managed care plans and related state data. It would require examination of plan encounter data, financials, audits, savings rebates, medical loss ratios, provider credentialing, claims payment timeliness, denials, prior authorizations, consumer complaints, and quality measures such as HEDIS and performance improvement projects. The committee could issue periodic reports and recommendations to the Legislature, identify needed statutory or rule changes, and develop a long-term action plan for Medicaid.
If enacted, HB 935 would add a new legislative oversight structure to Florida law and expand formal legislative access to Medicaid program information. It would require the Auditor General and the Agency for Health Care Administration to maintain a data-sharing agreement, give the committee access to relevant records and testimony, and require AHCA to notify the committee before changing Medicaid managed care capitation rates and to share related reports. The bill would primarily affect the Agency for Health Care Administration, the Auditor General, Medicaid managed care organizations, and other entities holding Medicaid-related records or contracts with the state.
The bill’s stated goals suggest a generally favorable policy posture toward stronger oversight, transparency, and cost control in Medicaid. However, the available record shows no committee transcript or vote data, so there is no direct evidence of debate, support, or opposition from the legislative process beyond the bill’s referral and its eventual death in the Health Care Facilities & Systems Subcommittee. Its failure to advance indicates it did not secure enough support or priority to move forward.
The main points of potential contention are the bill’s broad oversight powers and the burden of expanded reporting and data access requirements. Stakeholders concerned about administrative workload, confidentiality, or legislative intrusion into agency and managed care operations could object to the committee’s access to records, authority to compel testimony, and mandatory pre-notification of capitation rate changes. Supporters would likely emphasize accountability, budget discipline, and improved Medicaid outcomes, while critics may worry that the bill could slow rate-setting or increase compliance demands on AHCA and managed care plans.